TCOV
IONS icon

Trust Company of Vermont’s Ionis Pharmaceuticals IONS Stock Holding History

Trust Company of Vermont’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16
Closed -$1K – 942
2019
Q3 		$1K Hold
16
– – ﹤0.01% 968
2019
Q2 		$1K Hold
16
– – ﹤0.01% 992
2019
Q1 		$1K Buy
+16
New +$1.03K ﹤0.01% 949

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Trust Company of Vermont's IONS Position: Q4 2019 in Review

Trust Company of Vermont sold out of Ionis Pharmaceuticals (IONS) in Q4 2019, closing a stake of 16 shares — an estimated $1K sold.

Trust Company of Vermont first reported a position in IONS in Q1 2019 and held it in 3 quarters. The position peaked at $1K in Q3 2019. 391 funds tracked by Wall St. Rank hold IONS as of Q4 2019.

  • Trust Company of Vermont reported no remaining Ionis Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Trust Company of Vermont sold 16 Ionis Pharmaceuticals shares in Q4 2019, an estimated $1K.
  • Trust Company of Vermont first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Trust Company of Vermont's Ionis Pharmaceuticals position peaked at $1K in Q3 2019.
  • 391 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2019.

Based on Trust Company of Vermont's 13F filing for Q4 2019, filed 6 Feb 2020.